Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human LPAR3 Antikörper:
anti-Mouse (Murine) LPAR3 Antikörper:
anti-Rat (Rattus) LPAR3 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal LPAR3 Primary Antibody für IF (p), IHC (p) - ABIN681133
Chen, Zhang, Deng, Liu, Yang, Wu, Yu: Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI. in Biochemical and biophysical research communications 2017
Human Polyclonal LPAR3 Primary Antibody für IHC, IHC (p) - ABIN4331421
Leve, Peres-Moreira, Binato, Abdelhay, Morgado-Díaz: LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways. in PLoS ONE 2015
EDG4 (zeige LPAR2 Antikörper) and EDG7 map to q2.1 of pig chromosome 2 (SSC2 (zeige ELOVL2 Antikörper)) and q2.6-3.2 of pig chromosome6 (SSC6), respectively
EDG7 was regulated by pregnancy stage and status. EDG7 expression was highest on d 12 pregnancy, and localized to the luminal and glandular epithelium, and EDG7 mRNA levels were elevated by estrogen in the endometrium.
The results indicate that LPA2 (zeige LPAR2 Antikörper) and LPA3 receptors play opposing roles during red blood cells differentiation.
myeloma cells stimulate mesenchymal stem cells (MSCs to produce autotaxin (zeige ENPP2 Antikörper), an indispensable enzyme for the biosynthesis of lysophosphatidic acid, and LPA receptor 1 (LPA1 (zeige LPAR1 Antikörper)) and 3 (LPA3) transduce opposite signals to MSCs to determine the fate of MSCs.
Expression profiles reveal LPAR3 (lysophosphatidic acid receptor 3) as a mediator for mitotic phosphorylation-driven pancreatic cell motility and invasion. Together, this work identifies YAP (zeige YAP1 Antikörper) as a novel regulator of pancreatic cancer cell motility, invasion and metastasis.
These data indicated that the expression of LPA receptor 3 was increased in human triple-negative breast cancers and is associated with tumor metastatic ability.
Suggest that LPA2 (zeige LPAR2 Antikörper) and LPA3 may function as a molecular switch and play opposing roles during megakaryopoiesis of K562 cells.
The results demonstrate LPA (zeige APOA Antikörper)-stimulated migration in oral carcinoma cells through LPAR3, mediated further by PKC (zeige PRRT2 Antikörper), which acts either in concert with or independently of EGFR (zeige EGFR Antikörper) transactivation
Findings indicate lysophosphatidic acid (LPA (zeige APOA Antikörper))-lysophosphatidic acid receptor-Galpha13 (zeige GNA13 Antikörper) signaling node as a therapeutic target for pancreatic cancer treatment and control.
LPA3 mRNA is clearly expressed in human PANC-1 tumor cells.
Lysophosphatidic acid (LPA) increased hepatocellular carcinoma cells cell invasion, which was LPA-receptor dependent.
in the normal human menstrual cycle, lysophosphatidic acid receptor 3 messenger RNA and protein expression change, indicating that this gene may be related to the function of the endometrium.
These results indicate that ATX (zeige ENPP2 Antikörper)-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary induces decidualization via the canonical HB-EGF (zeige HBEGF Antikörper) and COX-2 (zeige COX2 Antikörper) pathways.
Lpar3(-/-) female mice had delayed embryo implantation.
These results suggest that LPA3 receptor-mediated amplification of spinal LPA production is required for the development of paclitaxel-induced neuropathic pain.
These results suggest that LPA signaling through LPA3 may inhibit angiogenesis and fibroblast activation in mouse lung cancer cells
The thromboxane A(2) receptor agonist 11-deoxy PGF (zeige PTGFR Antikörper)(2alpha) can partially alleviate embryo crowding in the Lpar3((-/-)) females and embryo crowding likely contributes to reduced litter size in the Lpar3((-/-)) females.
Lysophosphatidic acid, via LPA(1 (zeige LPAR1 Antikörper)) and LPA(3) receptors, may play a significant role in inducing and/or sustaining the massive infiltration of leukocytes during inflammation
Luminal epithelium localization and up-regulation by progesterone differentiate LPA3 from the other nine LP receptors and may underlie its essential role in embryo implantation.
LPA(1 (zeige LPAR1 Antikörper)-3) are differentially expressed in the central nervous system and their expression is upregulated in response to injury.
Lysophosphatidic acid receptors LPA3 and LPA1 (zeige LPAR1 Antikörper) promote CXCL12 (zeige CXCL12 Antikörper)-mediated smooth muscle progenitor cell recruitment.
LPA3 receptor-mediated signalling has an influence on embryo implantation, and there is a linkage between LPA signalling and prostaglandin biosynthesis.
This gene encodes a member of the G protein-coupled receptor family, as well as the EDG family of proteins. This protein functions as a cellular receptor for lysophosphatidic acid and mediates lysophosphatidic acid-evoked calcium mobilization. This receptor couples predominantly to G(q/11) alpha proteins.
endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7
, lysophosphatidic acid receptor 3
, LPA receptor 3
, LPA receptor EDG7
, calcium-mobilizing lysophosphatidic acid receptor LP-A3
, endothelial cell differentiation gene 7
, lysophosphatidic acid receptor Edg-7
, endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 7
, putative G protein-coupled receptor snGPCR32